In This Section

Erin R. Camac, DO, FCCP

Associate Professor, Clinical Thoracic Medicine and Surgery
Associate Program Director, Internal Medicine Residency Program
Unit Based Medical Director, 6 East, Temple University Hospital

Erin Camac
For Patients
Contact Information

Contact Information

Phone

215-707-8113
About Me

Clinical Interests

  • Interstitial lung disease
  • Connective-tissue disease associated with interstitial lung disease
  • Idiopathic pulmonary fibrosis
  • Hypersensitivity pneumonitis
  • Occupational lung disease
  • Drug-induced respiratory disease
  • Mycobacteria-related lung disease
  • Interstitial Pneumonitis with autoimmune features 

Research Interests

  • Connective-tissue interstitial lung disease (CT-ILD)
  • Idiopathic pulmonary fibrosis
  • Associated interstitial lung disease
  • Interstitial Pneumonitis with autoimmune features
Education, Training & Credentials

Educational Background

  • Fellowship, Pulmonary and Critical Care, Temple University Hospital, Philadelphia, PA
  • Residency, Internal Medicine, Temple University Hospital, Philadelphia, PA
  • DO, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Certifications

  • Internal Medicine
  • Pulmonary Disease
  • Critical Care Medicine

Memberships

  • American Thoracic Society
  • American College of Chest Physicians
  • Fellow, Philadelphia College of Physicians

Honors & Awards

  • Outstanding Intensive Care Faculty Educator Award, 2018-2019
  • Outstanding Faculty Educator Award 2016-2017
  • Outstanding Intensive Care Faculty Educator Award 2016-2017
  • Core Faculty, Internal Medicine Residency Program: Director of SIM Education
  • Medical Director, Ventilator Rehabilitation Unit
  • Chief Fellow, Pulmonary and Critical Care Medicine, 2014-2015
  • Outstanding Fellow Educator Award, 2013
  • Most Outstanding Ambulatory Care Award, 2012
  • The Frederic H. Barth Memorial Award for Pulmonary Medicine, 2009
Publications

Selected Publications

2017- Present Co-Investigator for the CLEANUP IPF trial and the STRIVE-IPF Trial

2016 Co-Investigator for the ART-IPF Trial, The ZEPHYR Trial, The RETHINC Trial

2015  Co-Investigator for the RIFF Trial

Narewski ER, Blackford AL, Lammi MR, et al; for the Long-Term Oxygen Treatment Trial Research Group. Clinical Differences in COPD patients with variable patterns of hypoxemia. Chronic Obstr Pulm Dis (Miami). 2018; 5(3): 167-176.
doi: http://doi.org/10.15326/jcopdf.5.3.2017.0175

May 18th, 2018 Thematic Poster, ATS 2018 Int. Conference in San Diego, CA
Weight Loss in Patients on Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis (IPF): A Single Center Retrospective Review.
C. Gutierrez MD, J Kraft MD, J Galli MD, E Narewski, DO

May 18th, 2018 Thematic Poster, ATS 2018 Int. Conference in San Diego, CA
Patients with Interstitial Pneumonia with Autoimmune Features May Have Improved Lung Transplant Survival Compared to Those with IPF.
Y. Dotan, MD, A. Chatterjee MD, E. Narewski DO, A.J. Mamary MD

May 18th, 2018 Thematic Poster, ATS 2018 Int. Conference in San Diego, CA
Do Demographics, Pattern of Lung Disease, or Connective Tissue Disease (CTD) Diagnosis Predict the Response of Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD) Patients to Mycophenolate Mofetil?
J. Ramzy MD, R. Townsend MD, S Codella MD, H Zhao, E Narewski DO

Accepted for Publication (Taylor and Francis 2018)  Essentials of Clinical Pulmonology: ISBN-13: 9781444186468, Publication Date 5/22/18
Chapter 44 –Asbestosis, Pneumoconiosis, and Other Occupational Lung Diseases
Erin R. Narewski DO, Joseph Ramzy MD, Jennifer Kraft MD, Richard Ngo

Accepted for Publication (Taylor and Francis 2018)  Essentials of Clinical Pulmonology: ISBN-13: 9781444186468, Publication Date 5/22/18
Chapter 45 –Drug Induced Lung Disease and Radiation Induced Lung Disease
Erin R. Narewski DO, Scott Simpson, MD

Narewski ER, Kim V, Marchetti N, Jacobs MR, Criner GJ. Is methicillin- resistant Staphylococcus aureus colonization associated with worse outcomes in COPD hospitalizations? Chronic Obstr Pulm Dis (Miami). 2015; 2(3): 252-258.
doi: http://dx.doi.org/10.15326/jcopdf.2.3.2014.0147 -
See more at: http://journal.copdfoundation.org/jcopdf/ArticleType/ArticleView/Article...

May 18, 2015  Thematic Poster, ATS 2015 International Conference in Denver, CO
Short-Term Impact of Frequency of COPD Exacerbations on Quality of Life
E. Narewski DO, H. Voelker, BS, M. Nayeemuddin, MD, S. Aaron, MD, R. Albert, MD, N. Anthonisen, MD, R. Casaburi, MD, PhD, J. Connett, PhD, W. Bailey, MD, A. Cooper, Jr, MD, J. Curtis, MD, M. Dransfield, MD, M. Han, MD, S. Lazarus, MD, N. Marchetti, MD, B. Make, MD, F. Martinez, MD, D. Niewoehner, MD, J. Porsasz, MD, PhD, R. Reed, MD, S. Scharf, MD, PhD,  F. Sciurba, MD, D. Sin, MD, MPH, G. Washko, MD, P. Woodruff, MD, MPH, and G. Criner, MD for the COPD Clinical Research Network and the Canadian Institutes of Health Research

May 18, 2015  Poster Discussion, ATS 2015 International Conference in Denver, CO
Short-Term Impact of Hospitalized vs Non-Hospitalized COPD Exacerbations on General and Disease-Specific Quality of Life
E. Narewski DO, H. Voelker, BS, M. Nayeemuddin, MD, S. Aaron, MD, R. Albert, MD, N. Anthonisen, MD, R. Casaburi, MD, PhD, J. Connett, PhD, W. Bailey, MD, A. Cooper, Jr, MD, J. Curtis, MD, M. Dransfield, MD, M. Han, MD, S. Lazarus, MD, N. Marchetti, MD, B. Make, MD, F. Martinez, MD, D. Niewoehner, MD, J. Porsasz, MD, PhD, R. Reed, MD, S. Scharf, MD, PhD,  F. Sciurba, MD, D. Sin, MD, MPH, G. Washko, MD, P. Woodruff, MD, MPH, and G. Criner, MD for the COPD Clinical Research Network and the Canadian Institutes of Health Research

May 18, 2015  Thematic Poster, ATS 2015 International Conference in Denver, CO
Physiologic Differences In COPD Patients With Mild-Moderate Hypoxemia At Rest +/-   Exertion Vs. Those Normoxemic At Rest Who Desaturate Only With Exertion   
Erin R. Narewski, DO, Yuka Furuya, MD, Chandra Dass, MD, Parag Desai, MD, Mahatsi Rittinger, Phillip Diaz, MD, Mohamed Ali, MD, and Gerard J. Criner, MD for the Long-Term Oxygen Treatment Trial (LOTT) Research Group

May 19, 2014  Thematic Poster, ATS 2014 International Conference in San Diego, CA
Clinical Differences In COPD Patients With Mild-Moderate Hypoxemia At Rest +/-   Exertion Vs. Those Normoxemic At Rest Who Desaturate Only With Exertion   
Erin R. Narewski, DO, Amanda Blackford, ScM, Parag B. Desai, MD, Matthew R. Lammi, MD, Anne L. Fuhlbrigge, MD, MS, Xavier Soler, MD, PhD, Richard Albert, MD, and Gerard J. Criner, MD for the Long-Term Oxygen Treatment Trial (LOTT) Research Group

Awaiting Publication (Springer)  Pulmonary Medicine Essentials
Chapter 41 – Drug Induced Lung Disorders             
Alex Swift MD, Erin R. Narewski DO

Awaiting Publication (Springer)  Pulmonary Medicine Essentials
Chapter 77 – Mycobacterium Tuberculosis            
Erin R. Narewski DO, Robert Bettiker MD, Jocelyn Edathil MD, Florence Momplasir MD

Awaiting Publication (Springer)  Pulmonary Medicine Essentials
Chapter 78 – Non-Tuberculous Mycobacterium       
Erin R. Narewski DO, Victor Kim MD, Ian Sheffer MD

Awaiting Publication (Springer)  Pulmonary Medicine Essentials
Chapter 32 –Approach to the Evaluation and Diagnosis of ILD
Erin R. Narewski DO